Best Lawyers Switzerland 2014 - 2021

Recommended for Biotechnology Law, Intellectual Property Law.

Who's Who Legal (Global 2020) - "Healthcare"

"Matthias Staehelin has an impressive transactional and intellectual property practice that he leverages to support clients in a variety of financing, dealmaking and life sciences issues."

Who's Who Legal Thought Leaders (Global 2020) - "Healthcare"

"Stefan Kohler is a regulatory specialist who assists domestic and international clients in navigating healthcare and life sciences regulations." He is listed as Global Elite Thought Leader.

Who's Who Legal Thought Leaders (Switzerland 2020) - "Patents"

"Stefan Kohler possesses strong experience in IP and technology law, and is active in a plethora of industries including biotech, cosmetics and healthcare."

Who's Who Legal Thought Leaders (Switzerland 2020) - "Life Sciences"

"Stefan Kohler is a standout lawyer distinguished for his expertise in IP law. He brings significant value to clients due to his insights into the biotech, healthcare and pharma markets." 

Who's Who Legal Thought Leaders (Global 2020) - "Life Sciences - Transactional"

Recommended for Life Sciences - Transactional

BILANZ-Ranking "Top-Anwaltskanzleien 2020" der Schweiz

VISCHER wurde in den Branchen Chemie, Medizinaltechnik und Pharma als eine der fünf am häufigsten empfohlenen Kanzleien ausgezeichnet.

Legal 500 (EMEA 2020) - "Healthcare and Life Sciences"

"VISCHER has a strong track record in transactions in the life sciences space, in which it acts for companies, entrepreneurs and investors alike. It is also well versed in advising clients on compliance matters, administrative procedures and other regulatory matters. Stefan Kohler has longstanding experience in the sector and further advises on IP and technology law. He jointly leads the practice alongside Matthias Staehelin in Basel, who is a key contact for M&A, IPOs and financings in this space. Christian Wyss, also in Basel, has considerable knowledge in setting up contracts and assisting start-ups."

Chambers Europe 2020 - Life Sciences

Stefan Kohler advises on licensing agreements for drug development and commercialisation, with further activity in product launches. He also offers experience in pricing and reimbursement matters.

Chambers Europe 2020 - Life Sciences

Matthias Staehelin advises medical device and biopharmaceutical companies on financing mandates, with additional experience in licensing agreements.

You are currently offline. Some pages or content may fail to load.